Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 11

    1.

    Adjunctive resectional lung surgery for extensively drug-resistant tuberculosis.

    Dravniece G, Cain KP, Holtz TH, Riekstina V, Leimane V, Zaleskis R.

    Eur Respir J. 2009 Jul;34(1):180-3.PMID: 19567603 [PubMed - indexed for MEDLINE]Related articles

    2.

    Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia.

    Riekstina V, Leimane V, Holtz TH, Leimans J, Wells CD.

    Int J Tuberc Lung Dis. 2007 May;11(5):585-7.PMID: 17439686 [PubMed - indexed for MEDLINE]Related articles

    3.

    Multidrug-resistant tuberculosis management in resource-limited settings.

    Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.

    Emerg Infect Dis. 2006 Sep;12(9):1389-97.PMID: 17073088 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.

    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.

    Ann Intern Med. 2006 May 2;144(9):650-9.PMID: 16670134 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.

    Leimane V, Leimans J.

    Euro Surveill. 2006;11(3):29-33.PMID: 16567876 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Multidrug-resistant tuberculosis detection, Latvia.

    Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz TH, Wells CD, Leimane V.

    Emerg Infect Dis. 2005 Sep;11(9):1461-3.PMID: 16229783 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.

    Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, Zarovska E, Rich ML, Fraser HS, Alarcón E, Cegielski JP, Grzemska M, Gupta R, Espinal M.

    Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5.PMID: 15971391 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Risk factors for early relapse of tuberculosis in Latvia]

    Riekstinia V, Torp L, Leĭmane V.

    Probl Tuberk Bolezn Legk. 2005;(1):43-7. Russian. PMID: 15801638 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study.

    Leimane V, Riekstina V, Holtz TH, Zarovska E, Skripconoka V, Thorpe LE, Laserson KF, Wells CD.

    Lancet. 2005 Jan 22-28;365(9456):318-26.PMID: 15664227 [PubMed - indexed for MEDLINE]Related articles

    10.

    Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

    Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, Tupasi TE, Vink K, Jaramillo E, Espinal MA.

    Int J Tuberc Lung Dis. 2004 Nov;8(11):1382-4.PMID: 15581210 [PubMed - in process]Related articles

    11.

    Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia.

    Morozova I, Riekstina V, Sture G, Wells C, Leimane V.

    Int J Tuberc Lung Dis. 2003 Sep;7(9):903-6.PMID: 12971677 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...